Veracyte to Release Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026

Core Viewpoint - Veracyte, Inc. is set to release its financial results for the fourth quarter and full year of 2025 on February 25, 2026, and anticipates significant revenue growth compared to the previous year [1]. Financial Results - For the fourth quarter of 2025, Veracyte expects total revenue to be between $138 million and $140 million, reflecting an increase of 16% to 18% compared to the same period in 2024 [1]. Upcoming Events - The company will host a conference call and webcast on February 25, 2026, at 4:30 p.m. Eastern Time to discuss the financial results and provide a business update [1]. - Veracyte will participate in the 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026, at 9:45 a.m. Pacific Time [1]. - The company is also scheduled to participate in the Wolfe Research Healthcare Conference and the Jefferies Global Healthcare Conference in November 2025 [1].